{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:51:22Z","timestamp":1790477482841,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/fpc.0000000000000169","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T14:14:13Z","timestamp":1439993653000},"page":"541-547","source":"Crossref","is-referenced-by-count":19,"title":["Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort"],"prefix":"10.1097","volume":"25","author":[{"given":"Ivete M.","family":"da Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline S.","family":"Gasparotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosmeri K.","family":"Lazzaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina K.","family":"Notti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Sprinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa S.","family":"Mattevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20210213","first-page":"48","article-title":"Antiretroviral medications as prevention: will the new paradigm reverse the HIV epidemic Minn M","volume":"95","author":"Henry","year":"2012","journal-title":"ed"},{"key":"R3-3-20210213","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1310\/hct1304-189","article-title":"Renal toxicity associated with antiretroviral therapy.","volume":"13","author":"Calza","year":"2012","journal-title":"HIV Clin Trials"},{"key":"R4-3-20210213","first-page":"125","article-title":". Renal toxicity in HIV-infected patients receiving HAART including tenofovir.","volume":"3","author":"Madeddu","year":"2006","journal-title":"Infez Med"},{"key":"R5-3-20210213","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.ackd.2009.07.009","article-title":"Antiretroviral medications: adverse effects on the kidney.","volume":"17","author":"Jao","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"R6-3-20210213","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2009.142","article-title":"The nephrotoxic effects of HAART.","volume":"5","author":"Izzedine","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"R7-3-20210213","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2217\/hiv.10.42","article-title":"Recent developments in HIV-related kidney disease.","volume":"4","author":"Estrella","year":"2010","journal-title":"HIV Ther"},{"key":"R8-3-20210213","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/503566","article-title":"HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.","volume":"42","author":"Roling","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R9-3-20210213","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/00365548.2012.712213","article-title":". Incidence of renal toxicity in HIV-infected, antiretroviral-naive patients starting tenofoviremtricitabine associated with efavirenz, atazanavirritonavir, or lopinavirritonavir.","volume":"45","author":"Calza","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"R10-3-20210213","first-page":"148","article-title":"Tenofovir-induced nephrotoxicity: myths and facts.","volume":"23","author":"Gupta","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R11-3-20210213","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ndt\/gfh640","article-title":". Tenofovir-induced acute renal failure in an HIV patient with normal renal function.","volume":"20","author":"Krummel","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R12-3-20210213","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","article-title":". Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.","volume":"24","author":"Mocroft","year":"2010","journal-title":"AIDS"},{"key":"R13-3-20210213","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/QAD.0b013e3281fc9320","article-title":"Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.","volume":"21","author":"Crane","year":"2007","journal-title":"AIDS"},{"key":"R14-3-20210213","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1081\/NCN-100002341","article-title":"Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs.","volume":"20","author":"Cihlar","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"R15-3-20210213","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pharmthera.2005.07.005","article-title":"Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion.","volume":"109","author":"Robertson","year":"2006","journal-title":"Pharmacol Ther"},{"key":"R16-3-20210213","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1002\/jps.22655","article-title":"Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.","volume":"100","author":"Griffin","year":"2011","journal-title":"J Pharm Sci"},{"key":"R17-3-20210213","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","article-title":"Drug transport by organic anion transporters (OATs).","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacol Ther"},{"key":"R18-3-20210213","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1128\/AAC.00251-06","article-title":". Mechanism of active renal tubular efflux of tenofovir.","volume":"50","author":"Ray","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-3-20210213","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/jpet.105.084301","article-title":"Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6).","volume":"314","author":"Bleasby","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-3-20210213","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1124\/pr.111.005553","article-title":"The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.","volume":"64","author":"Michaud","year":"2012","journal-title":"Pharmacol Rev"},{"key":"R21-3-20210213","first-page":"1","article-title":"Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged 18 months and for HIV infection and AIDS among children aged 18 months to 13 years - United States, 2008.","volume":"57","author":"Schneider","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"R22-3-20210213","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1469-1809.2006.00270.x","article-title":"Application of an African Ancestry Index as a genomic control approach in a Brazilian population.","volume":"70","author":"Zembrzuski","year":"2006","journal-title":"Ann Hum Genet"},{"key":"R23-3-20210213","doi-asserted-by":"crossref","first-page":"608415","DOI":"10.1155\/2013\/608415","article-title":". Genetic markers associated to dyslipidemia in HIV-infected individuals on HAART.","volume":"2013","author":"Lazzaretti","year":"2013","journal-title":"Scientific World Journal"},{"key":"R24-3-20210213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.ajkd.2012.06.016","article-title":". Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly.","volume":"61","author":"Kilbride","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R25-3-20210213","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/qjmed\/hcr077","article-title":"Estimating glomerular filtration rate: comparison of the CKD-EPI and MDRD equations in a large UK cohort with particular emphasis on the effect of age.","volume":"104","author":"Carter","year":"2011","journal-title":"QJM"},{"key":"R26-3-20210213","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"R27-3-20210213","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e31815e7478","article-title":"Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients.","volume":"47","author":"Kiser","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-3-20210213","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/508546","article-title":". Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.","volume":"194","author":"Izzedine","year":"2006","journal-title":"J Infect Dis"},{"key":"R29-3-20210213","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":". Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.","volume":"48","author":"Rodriguez-Novoa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R30-3-20210213","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2217\/pgs.09.115","article-title":"Pharmacogenetics of tenofovir treatment.","volume":"10","author":"Rodriguez-Novoa","year":"2009","journal-title":"Pharmacogenomics"},{"key":"R31-3-20210213","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/cis772","article-title":". Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study.","volume":"55","author":"Nishijima","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R32-3-20210213","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.fpc.0000236338.41799.57","article-title":"Pharmacogenetics of HIV therapy.","volume":"16","author":"Owen","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"R33-3-20210213","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps.","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"R34-3-20210213","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1089\/aid.2011.0261","article-title":". UGT1A1 28 variant allele is a predictor of severe hyperbilirubinemia in HIV-infected patients on HAART in southern Brazil.","volume":"28","author":"Turatti","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R35-3-20210213","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"R37-3-20210213","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/ndt\/gfr657","article-title":"Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients.","volume":"27","author":"Ibrahim","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R38-3-20210213","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/QAD.0000000000000103","article-title":"Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity.","volume":"28","author":"Yombi","year":"2014","journal-title":"AIDS"},{"key":"R39-3-20210213","doi-asserted-by":"crossref","first-page":"e26042","DOI":"10.1371\/journal.pone.0026042","article-title":"Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in Brazil.","volume":"6","author":"Menezes","year":"2011","journal-title":"PLoS One"},{"key":"R40-3-20210213","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.tpj.6500403","article-title":". Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.","volume":"7","author":"Haenisch","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"R41-3-20210213","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/mol.110.070714","article-title":". Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379.","volume":"80","author":"Haenisch","year":"2011","journal-title":"Mol Pharmacol"},{"key":"R42-3-20210213","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/FPC.0000000000000046","article-title":"Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379.","volume":"24","author":"Werk","year":"2014","journal-title":"Pharmacogenet Genomics"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T02:18:24Z","timestamp":1748571504000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201511000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000169","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}